Amyotrophe Lateralsklerose

Lernziele

Klinisches Bild und unterschiedliche Verlaufsformen der amyotrophen Lateralsklerose (ALS) Klinische, elektrophysiologische, laborchemische, bildgebende Diagnostik Möglichkeiten der neuroprotektiven und insbesondere der symptomatischen Therapie

Literatur

• 1 Bruijn L I, Miller T M, Cleveland D W. Unraveling the mechanisms involved in motor neuron degeneration in ALS.  Annu Rev Neurosci. 2004;  27 723-749
• 2 Rosen D. et al . Mutations in Cu / Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.  Nature. 1993;  362 59-62
• 3 Pasinelli P, Brown R H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics.  Nat Rev Neurosci. 2006;  7 710-723
• 4 Cronin S. et al . A genome-wide association study of sporadic ALS in a homogenous Irish population.  Hum Mol Genet. 2008;  17 768-774
• 5 Cronin S. et al . Screening for replication of genome-wide SNP associations in sporadic ALS.  Eur J Hum Genet. 2009;  17 213-218
• 6 Schymick J C. et al . Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data.  Lancet Neurol. 2007;  6 322-328
• 7 Traynor B J, Singleton A. Genome-wide association studies and ALS: are we there yet?.  Lancet Neurol. 2007;  6 841-843
• 8 van Es M A. et al . ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study.  Lancet Neurol. 2007;  6 869-877
• 9 van Es M A. et al . Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis.  Nat Genet. 2008;  40 29-31
• 10 Muller-Jensen A, Bernhardt W. [Myatrophic lateralsclerosis].  Nervenarzt. 1973;  44 143-149
• 11 Czaplinski A. et al . Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis.  Eur J Neurol. 2004;  11 567-568
• 12 Norris F H, Smith R A, Denys E H. Motor neurone disease: towards better care.  Br Med J (Clin Res Ed). 1985;  291 259-262
• 13 McCullagh S. et al . Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction.  J Neurol Sci. 1999;  169 43-48
• 14 Younger D S. et al . Primary lateral sclerosis. A clinical diagnosis reemerges.  Arch Neurol. 1988;  45 1304-1307
• 15 Brugman F. et al . Primary lateral sclerosis as a phenotypic manifestation of familial ALS.  Neurology. 2005;  64 1778-1779
• 16 Misuri G. et al . Mechanism of CO(2) retention in patients with neuromuscular disease.  Chest. 2000;  117 447-453
• 17 Piquet M A. [Nutritional approach for patients with amyotrophic lateral sclerosis].  Rev Neurol (Paris). 2006;  162, Spec No 2 4S177-4S187
• 18 Funalot B. et al . High metabolic level in patients with familial amyotrophic lateral sclerosis.  Amyotroph Lateral Scler. 2008;  16 1-5
• 19 Ringholz G M. et al . Prevalence and patterns of cognitive impairment in sporadic ALS.  Neurology. 2005;  65 586-590
• 20 Ringholz G M, Greene S R. The relationship between amyotrophic lateral sclerosis and frontotemporal dementia.  Curr Neurol Neurosci Rep. 2006;  6 387-392
• 21 Kurt A. et al . Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management.  CNS Drugs. 2007;  21 279-291
• 22 Brooks B R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases / Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial . „Clinical limits of amyotrophic lateral sclerosis” workshop contributors.  J Neurol Sci. 1994;  124 (Suppl.) 96-107
• 23 Brooks B R. et al . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;  1 293-299
• 24 Chio A. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis.  J Neurol. 1999;  246 (Suppl. 3) III1-5
• 25 Chio A. Update on ISI survey: Europe, North America and South America.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;  1 (Suppl. 1) S9-11
• 26 Andersen P M. et al . EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives.  Eur J Neurol. 2005;  12 921-938
• 27 Andersen P M. et al . Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group.  Amyotroph Lateral Scler. 2007;  8 195-213
• 28 Dengler R, Troger M. Classification of ALS – do we know enough?.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;  1 68-69
• 29 Troger M, Dengler R. The role of electromyography (EMG) in the diagnosis of ALS.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;  1 (Suppl. 2) S33-40
• 30 Dengler R. et al . Amyotrophic lateral sclerosis: new developments in diagnostic markers.  Neurodegener Dis. 2005;  2 177-184
• 31 Eisen A, Stewart H. Not-so-benign fasciculation.  Ann Neurol. 1994;  35 375-376
• 32 Dengler R. Neue Überlegungen zur klinisch-neurophysiologischen Diagnostik bei ALS. Die Awaji-Kriterien.  Klinische Neurophysiologie. 2008;  39 164-168
• 33 de Carvalho M. et al . Electrodiagnostic criteria for diagnosis of ALS.  Clin Neurophysiol. 2008;  119 497-503
• 34 Jaspert A. et al . Multifocal motor neuropathy: clinical and electrophysiological findings.  J Neurol. 1996;  243 684-692
• 35 de Carvalho M. et al . Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;  6 17-28
• 36 Dengler R. Klinik und Differenzialdiagnose. In: Dengler R, Ludolph A, Zierz S, Hrsg Amyotrophe Lateralsklerose. Stuttgart, New York; Thieme Verlag 2000: 59-64
• 37 Urban P P, Vogt T, Hopf H C. Corticobulbar tract involvement in amyotrophic lateral sclerosis. A transcranial magnetic stimulation study.  Brain. 1998;  121 1099-1108
• 38 Urban P P, Wicht S, Hopf H C. Sensitivity of transcranial magnetic stimulation of cortico-bulbar vs. cortico-spinal tract involvement in Amyotrophic Lateral Sclerosis (ALS).  J Neurol. 2001;  248 850-855
• 39 Claus D. et al . Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis.  J Neurol Sci. 1995;  129 (Suppl.) 30-34
• 40 Chen R. et al . The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee.  Clin Neurophysiol. 2008;  119 504-532
• 41 Komissarow L. et al . Triple stimulation technique (TST) in amyotrophic lateral sclerosis.  Clin Neurophysiol. 2004;  115 356-360
• 42 Kollewe K, Andersen P M, Borasio G D. et al . Klinische Leitlinien zur Behandlung der Amyotrophen Lateralsklerose.  Nervenheilkunde. 2008;  4 302-316
• 43 Johnson W G. Hexosaminidase deficiency: a cause of recessively inherited motor neuron diseases.  Adv Neurol. 1982;  36 159-164
• 44 Bensimon G, Lacomblez l, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS / Riluzole Study Group.  N Engl J Med. 1994;  330 585-591
• 45 Lacomblez L. et al . Long-term safety of riluzole in amyotrophic lateral sclerosis.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;  3 23-29
• 46 Lacomblez L. et al . Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis / Riluzole Study Group II.  Lancet. 1996;  347 1425-1431
• 47 Lacomblez L. et al . A confirmatory dose-ranging study of riluzole in ALS. ALS / Riluzole Study Group-II.  Neurology. 1996;  47 (6, Suppl. 4) S242-250
• 48 Traynor B J. et al . An outcome study of riluzole in amyotrophic lateral sclerosis – a population-based study in Ireland 1996–2000.  J Neurol. 2003;  250 473-479
• 49 Turner M R. et al . Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;  3 15-21
• 50 Gurney M E. Transgenic-mouse model of amyotrophic lateral sclerosis.  N Engl J Med. 1994;  331 1721-1722
• 51 Gurney M E. et al . Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.  Science. 1994;  264 1772-1775
• 52 Schutz B. et al . The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.  J Neurosci. 2005;  25 7805-7812
• 53 Forshew D A, Bromberg M B. A survey of clinicians' practice in the symptomatic treatment of ALS.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;  4 258-263
• 54 Giess R. et al . Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.  J Neurol Neurosurg Psychiatry. 2000;  69 121-123
• 55 Sancho J. et al . Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis.  Chest. 2004;  125 1400-1405
• 56 Heffernan C. et al . Nutritional management in MND / ALS patients: an evidence based review.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;  5 72-83
• 57 Kubler A. et al . Brain-computer communication: self-regulation of slow cortical potentials for verbal communication.  Arch Phys Med Rehabil. 2001;  82 1533-1539
• 58 Kubler A. et al . Patients with ALS can use sensorimotor rhythms to operate a brain-computer interface.  Neurology. 2005;  64 1775-1777
• 59 Lyall R A. et al . Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.  Brain. 2001;  124 2000-2013
• 60 Bourke S C. et al . Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.  Lancet Neurol. 2006;  5 140-147
• 61 Miller R G. et al . Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force.  Neurology. 1999;  52 1311-1323
• 62 Kuhnlein P. et al . Palliative care and circumstances of dying in German ALS patients using non-invasive ventilation.  Amyotroph Lateral Scler. 2008;  9 91-98
• 63 Brooks B R. et al . Treatment of pseudobulbar affect in ALS with dextromethorphan / quinidine: a randomized trial.  Neurology. 2004;  63 1364-1370